Journal of Clinical and Aesthetic Dermatology

APR 2018

An evidence-based, peer-reviewed journal for practicing clinicians in the field of dermatology

Issue link: https://jcadonline.epubxp.com/i/959274

Contents of this Issue

Navigation

Page 46 of 61

47 JCAD JOURNAL OF CLINICAL AND AESTHETIC DERMATOLOGY April 2018 • Volume 11 • Number 4 O R I G I N A L R E S E A R C H the pulse width was significantly less than the TRT value (>10ms), which improves safety of the treatment, considering the photo- type, without compromising the density of the emitted energy. This helps maintain high efficacy and precision in the light–tissue interaction. The unique feature of our study is that IPL therapy was applied as a monotherapy for inflammatory acne vulgaris, keeping fluence, pulse mode, and frequency of the sessions constant with satisfactory results. This is the first study to our knowledge in which energy was delivered in continuous and double- pulse modes, one after the other, on the same day for six treatment sessions without any adverse effects. There have been a few studies assessing the use of IPL therapy in inflammatory acne in the literature; however, our study included the largest cohort of patients (n=100). CONCLUSION IPL therapy with a 530nm to 1,200nm filter, delivering short and dense energy pulses and using the continuous and double-pulse modes, was demonstrated to be safe and effective as a monotherapy for the treatment of Grades 3 and 4 acne in women of child bearing age. ACKNOWLEDGMENTS The author wishes to acknowledge Sharad Mutalik, MBBS, DVD, head of the Department of Dermatology at Maharashtra Medical Foundation Joshi Hospital in Pune, India, for his valuable guidance in the preparation of this manuscript. REFERENCES 1. Williams C, Layton AM. Persistent acne in women: Implications for the patient and for therapy. Am J Clin Dermatol. 2006;7(5):281–290. 2. Lucky AW, Biro FM, Huster GA, et al. Acne vulgaris in premenarchal girls. An early sign of puberty associated with rising levels of dehydroepiandrosterone. Arch Dermatol. 1994;130(3):308–314. 3. Zaenglein AL, Graber EM, Thiboutot DM. Acne vulgaris and acneiform eruptions. Fitzpatrick's Dermatology In General Medicine. 7th ed. New York, NY: McGraw-Hill Medical; 2008: 690–703. 4. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998;139(5):846–850. 5. Mallon E, Newton JN, Klassen A, et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999;140(4):672–676. 6. Haider A, Shaw JC. Treatment of acne vulgaris. JAMA. 2004;292(6):726–735. 7. Leyden JJ. Therapy for acne vulgaris. N Engl J Med. 1997;336(16):1156 –1162. 8. Skidmore RA, Kovach R, Walker C, et al. Effects of subanti-microbial dose of doxycycline in treatment of moderate acne. Arch Dermatol. 2003; 139:459–464. 9. Ortonne JP. Oral isotretinoin treatment policy. Do we all agree?. Dermatology. 1997;195 Suppl 1:34–37; discussion 38–40. 10. Weiss JS. Current options for the treatment of acne vulgaris. Paediatr Dermatol. 1997;14(6):480–488. 11. Bojar RA, Cunliffe WJ, Holland KT. The short-term treatment of acne vulgaris with benzoyl peroxide: effects on the surface and follicular cutaneous microflora. Br J Dermatol. 1995;132(2):204–208. 12. Gollnick H, Schramm M. Topical therapy in acne. J Eur Acad Dermatol Venereol. 1998;11 Suppl 1:S8– S12; discussion S28–S9. 13. Ross JI, Snelling AM, Carnegie E, et al. Antibiotic- resistant acne: lessons from Europe. Br J Dermatol. 2003;148(3):467–478. 14. Sinnott SJ, Bhate K, Margolis DJ, Langan SM. Antibiotics and acne: an emerging iceberg of antibiotic resistance?. Br J Dermatol. 2016;175(6):1127–1128. 15. Rai R, Natarajan K. Laser and light based treatments of acne. Indian J Dermatol Venereol Leprol. 2013;79(3): 300–309. 16. Babilas P. Light-assisted therapy in dermatology: the use of intense pulsed light (IPL). Med Laser Appl. 2010;25:61–69. 17. Elman M, Lebzelter J. Light therapy in the treatment of acne vulgaris. Dermatol Surg. 2004;30(2 Pt 1):139–146. 18. Mohanan S, Parveen B, Annie Malathy P, Gomathi N. Use of intense pulsed light therapy for acne vulgaris in Indian skin—a case series. Int J Dermatol. 2012;51(4):473–476. 19. Patidar MV, Deshmukh AR, Khedkar MI. Efficacy of intense pulsed light therapy in the management of facial acne vulgaris: comparison of two different fluencies. Indian J Dermatol. 2016;61(5) 545–549. 20. Tank J, Kang S, Leyden J. Prevalence and risk factors of acne scarring among patients consulting dermatologists in the United States. J Drugs Dermatol. 2017;16(2): 97–102. 21. Leyden JJ, Tanghetti EA, Miller B, et al. Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial. Cutis. 2002;69(2 Suppl):12–19. 22. Eady EA, Bojar RA, Jones CE, et al. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria. Br J Dermatol. 1996;134(1):107–113. 23. Lucky AW, Maloney JM, Roberts J, et al. Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long-term (1 year) treatment. J Drugs Dermatol. 2007;6(10):981–987. 24. Gollnick H, Graupe K. Azelaic acid for the treatment of acne: comparative trials. J Dermatol Treat. 1989;1:27–30. 25. Goulden V. Safety of long-term high-dose minocycline in the treatment of acne. Br J Dermatol. 1996;134(4): 693–695. 26. Fernandez-Obregon AC. Azithromycin for the treatment of acne. Int J Dermatol. 2000;39(1):45– 50. 27. McCarty M, Rosso JQ. Chronic administration of oral trimethoprim-sulfamethoxazole for acne vulgaris. J Clin Aesthet Dermatol. 2011;4(8):58–66. 28. Bettoli V, Sarno O, Zauli S, et al. [What's new in acne? New therapeutic approaches]. Ann Dermatol Venereol. 2010;137 Suppl 2:S81–S85. Article in French. 29. Scalglion R, Dosirello G, Pazzaglia A. [Inflammatory acne resistant to conventional therapy. Efficacy and tolerability of isotretinoin]. G Ital Dermatol Venereol. 1989;124(3):XIII–XIX. Article in Italian. 30. Harper JC. Use of oral contraceptives for management of scne vulgaris: Practical considerations in real world practice. Dermatol Clin. 2016;34(2):159–165. 31. Kawada A, Wada T, Oisa N. Clinical effectiveness of once-daily levofloxacin for inflammatory acne with high concentrations in the lesions. J Dermatol. 2012;39(1):94–69. 32. Gessert CE, Bamford JT, Haller IV, Johnson BP. The role of zinc in rosacea and acne: further reflections. Int J Dermatol. 2014;53(1):128–129. 33. Fenner JA, Wiss K, Levin NA. Oral cephalexin for acne vulgaris: clinical experience with 93 patients. Paeditr Dermatol. 2008;25(2):179–183. 34. Stern RS, Rosa F, Baum C. Isotretinoin and pregnancy. J Am Acad Dermatol. 1984;10(5 Pt 1):851–854. 35. Dayal S, Amrani A, Sahu P, Jain VK. Jessner's solution vs. 30% salicylic acid peels: a comparative study of the efficacy and safety in mild-to- moderate acne vulgaris. Cosmet Dermatol.

Articles in this issue

Archives of this issue

view archives of Journal of Clinical and Aesthetic Dermatology - APR 2018